Fiber drink for asthma in kids
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests whether a liquid fiber drink can help children with asthma by reducing airway inflammation. Participants will drink either fiber or a placebo and be followed for about 4–6 weeks to see if their asthma improves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 17 years old.
- They must have been diagnosed with asthma within the last 2 years.
- They need to have high levels of certain markers of airway inflammation or have allergies confirmed by tests.
- No emergency room visits for asthma in the past month.
- Your child must be able to drink a liquid fiber or placebo drink and return for a follow-up visit 4–6 weeks later.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to diagnose asthma in children and teens using simple breathing tests. If your regular breathing test wasn't clear, this might give a more accurate answer.
This trial uses a simple inflammation test (inflammometry) to help diagnose asthma more accurately in people aged 6 and older who have been sent by their primary care doctor for standard breathing tests. It aims to improve the diagnosis process and reduce delays.
This study tests whether a sensor that tracks inhaler use can help children ages 4–17 with persistent or uncontrolled asthma. It aims to make managing asthma at home easier for caregivers.
This Phase 2 study checks how glycopyrronium bromide works in children with asthma, including its safety and how well inhaler dosing is tolerated. It also uses breathing tests and inhaler technique checks to confirm your child meets key asthma and lung function requirements.
This Phase 3 study compares a new inhaler (QMF149: indacaterol plus mometasone) against budesonide to see which works better and is safe for children ages 6 to under 12 with asthma. You may be able to join if your child is already on a stable low-dose steroid inhaler and still has symptoms.
This study aims to improve how we diagnose and treat asthma in children. It tests whether a personalized approach can help children whose asthma is not well controlled with current inhaler treatments.
Hear when a new Asthma in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.